Charité - Universitätsmedizin Berlin

Effective—and Tolerable: Acceptance and Side Effects of Intensified Exposure for Anxiety Disorders (2023) Heinig I, Knappe S, Hoyer J, Wittchen HU, Richter J, Arolt V, Deckert J, et al. Journal article Aberrant phase separation and nucleolar dysfunction in rare genetic diseases (2023) Mensah MA, Niskanen H, Magalhaes AP, Basu S, Kircher M, Sczakiel HL, Reiter AM, et al. Journal article What Kind of Patients Receive Inpatient and Day-Hospital Treatment in Departments of Psychosomatic Medicine and Psychotherapy in Germany? (2023) Doering S, Herpertz S, Hofmann T, Rose M, Imbierowicz K, Geiser F, Croy I, et al. Journal article Itching in Atopic Dermatitis: Patient-and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany (2023) Weisshaar E, Bentz P, Apfelbacher C, Haufe E, Heinrich L, Heratizadeh A, Abraham S, et al. Journal article Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany (2023) Müller-Felber W, Blaschek A, Schwartz O, Gläser D, Nennstiel U, Brockow I, Wirth B, et al. Journal article Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study (2023) Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Wenzel F, Stein S, Vogt S, et al. Journal article Daratumumab for the treatment of refractory ANCA-associated vasculitis (2023) Ostendorf L, Burns M, Wagner DL, Enghard P, Amann KU, Mei H, Eckardt KU, et al. Journal article Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices (2023) Charalampous P, Haagsma JA, Jakobsen LS, Gorasso V, Noguer I, Padron-Monedero A, Sarmiento R, et al. Journal article, Review article Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial (2023) Koehm M, Rossmanith T, Foldenauer AC, Herrmann E, Brandt-Jürgens J, Burmester GR, Kellner H, et al. Journal article Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP (2023) Matsushita K, Kaptoge S, Hageman SHJ, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Journal article